Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company"), a global pharmaceutical company, and Metsera, Inc. ("Metsera"), a clinical-stage biopharmaceutical company accelerating the ...
With early phase 1 data now out in the wild, metabolic disease outfit Metsera is wasting no time locking down supplies of its ...
Amneal Pharmaceuticals (AMRX) and Metsera have entered into a collaboration agreement to enable the efficient development and ...
The race to supply obesity drugs is so competitive that one early-stage startup is already striking a deal for commercial ...
On Monday, Amneal Pharmaceuticals Inc (AMRX) stock saw a modest uptick, ending the day at $8.32 which represents a slight increase of $0.13 or 1.59% from the prior close of $8.19. The stock opened at ...
Commerce Minister Piyush Goyal invited American companies to invest in India's electronics, data infrastructure, and ...
Delilah Alvarado Obesity drug startup Metsera said Tuesday it has signed a deal with manufacturing firm Amneal ...
Metsera, a biotech focused on obesity treatments, came out of stealth only this year, and its lead drug is still in early ...
It was a pleasure to meet Mr. Henry R. Kravis, Co-Founder & Co-Executive Chairman of global investment firm Kohlberg Kravis ...
Breast cancer remains the most common cancer among women in Canada, but early detection can save lives. PocketHealth is ...
Goyal posted on X, "Proud to hear the changing perception about India and the rising confidence in its growth story from ...
MolecuLight Inc., the global leader in fluorescence imaging technology for real-time detection of harmful bacteria and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback